Previous Article | Next Article 
Antimicrobial Agents and Chemotherapy, November 2006, p. 3956-3958, Vol. 50, No. 11
0066-4804/06/$08.00+0 doi:10.1128/AAC.00724-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.
Postantibiotic Effect of Ceftobiprole against 12 Gram-Positive Organisms
G. A. Pankuch and
P. C. Appelbaum*
Department of Pathology, Hershey Medical Center, Hershey, Pennsylvania 17033
Received 12 June 2006/
Returned for modification 1 July 2006/
Accepted 8 July 2006
The in vitro postantibiotic effects (PAEs), postantibiotic sub-MIC effects (PA-SMEs), and sub-MIC effects of ceftobiprole were determined for 12 gram-positive organisms. Pneumococcal, staphylococcal, and enterococcal PAEs were 1.4 to 3.1 h, 0 to 1.8 h, and 0 to 0.9 h, respectively. The PA-SMEs (0.4 times the MIC) for pneumococci, staphylococci, and enterococci were 4.8 to >10.3 h, 1.5 to 9.6 h, and 3.8 to >10.7 h, respectively.
* Corresponding author. Mailing address: Department of Pathology, Hershey Medical Center, P.O. Box 850, Hershey, PA 17033. Phone: (717) 531-5113. Fax: (717) 531-7953. E-mail:
pappelbaum{at}psu.edu.
Antimicrobial Agents and Chemotherapy, November 2006, p. 3956-3958, Vol. 50, No. 11
0066-4804/06/$08.00+0 doi:10.1128/AAC.00724-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Pankuch, G. A., Appelbaum, P. C.
(2009). Postantibiotic Effect of Ceftaroline against Gram-Positive Organisms. Antimicrob. Agents Chemother.
53: 4537-4539
[Abstract]
[Full Text]
-
Pankuch, G. A., Appelbaum, P. C.
(2009). Postantibiotic Effects of Telavancin against 16 Gram-Positive Organisms. Antimicrob. Agents Chemother.
53: 1275-1277
[Abstract]
[Full Text]
-
Pankuch, G. A., Appelbaum, P. C.
(2009). Postantibiotic Effect of Tigecycline against 14 Gram-Positive Organisms. Antimicrob. Agents Chemother.
53: 782-784
[Abstract]
[Full Text]
-
Anderson, S. D, Gums, J. G
(2008). Ceftobiprole: An Extended-Spectrum Anti-Methicillin-Resistant Staphylococcus aureus Cephalosporin. The Annals of Pharmacotherapy
42: 806-816
[Abstract]
[Full Text]